Works matching DE "TUMOR-infiltrating immune cells"
Results: 1774
Metabolic Regulation of Tumor Microenvironment with Biohybrid Bacterial Bioreactor for Enhanced Cancer Chemo‐Immunotherapy.
- Published in:
- Advanced Functional Materials, 2023, v. 33, n. 35, p. 1, doi. 10.1002/adfm.202302728
- By:
- Publication type:
- Article
The role of mitochondria in tumor metastasis and advances in mitochondria-targeted cancer therapy.
- Published in:
- Cancer & Metastasis Reviews, 2024, v. 43, n. 4, p. 1419, doi. 10.1007/s10555-024-10211-9
- By:
- Publication type:
- Article
PD-L1 expression in high-risk non-muscle invasive bladder cancer is not a biomarker of response to BCG.
- Published in:
- World Journal of Urology, 2025, v. 43, n. 1, p. 1, doi. 10.1007/s00345-024-05392-5
- By:
- Publication type:
- Article
Associations between Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Histopathological Features in Cholangiocarcinoma.
- Published in:
- Digestive Diseases, 2025, v. 43, n. 1, p. 46, doi. 10.1159/000540958
- By:
- Publication type:
- Article
Tumor-Associated Senescent Macrophages, Their Markers, and Their Role in Tumor Microenvironment.
- Published in:
- Biochemistry (00062979), 2024, v. 89, n. 5, p. 839, doi. 10.1134/S0006297924050055
- By:
- Publication type:
- Article
Contactin-4 suppresses antitumor T cell responses by engaging amyloid precursor protein.
- Published in:
- Science Immunology, 2024, v. 9, n. 100, p. 1, doi. 10.1126/sciimmunol.adk7237
- By:
- Publication type:
- Article
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8<sup>+ </sup>T-myeloid cell networks in melanoma.
- Published in:
- Science Immunology, 2024, v. 9, n. 92, p. 1, doi. 10.1126/sciimmunol.adg7995
- By:
- Publication type:
- Article
Selective control of transposable element expression during T cell exhaustion and anti–PD-1 treatment.
- Published in:
- Science Immunology, 2023, v. 8, n. 88, p. 1, doi. 10.1126/sciimmunol.adf8838
- By:
- Publication type:
- Article
Impaired enolase 1 glycolytic activity restrains effector functions of tumor-infiltrating CD8<sup>+</sup> T cells.
- Published in:
- Science Immunology, 2019, v. 4, n. 31, p. 1, doi. 10.1126/sciimmunol.aap9520
- By:
- Publication type:
- Article
What can I TIL you? Decoding TCR antigens.
- Published in:
- Science Immunology, 2018, v. 3, n. 20, p. 1, doi. 10.1126/sciimmunol.aat0810
- By:
- Publication type:
- Article
Microdissection tools to generate organoids for modeling the tumor immune microenvironment.
- Published in:
- Microsystems & Nanoengineering, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41378-024-00756-8
- By:
- Publication type:
- Article
TIL immunotherapy – progress or necessity of science?
- Published in:
- Oncolog-Hematolog, 2023, n. 64, p. 30
- By:
- Publication type:
- Article
Emerging Immunotherapies for Advanced Non-Small-Cell Lung Cancer.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 128, doi. 10.3390/vaccines13020128
- By:
- Publication type:
- Article
Emerging Immunotherapies for Advanced Non-Small-Cell Lung Cancer.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 128, doi. 10.3390/vaccines13020128
- By:
- Publication type:
- Article
Therapeutic Anti-Tumor Efficacy of DC-Based Vaccines Targeting TME-Associated Antigens Is Improved When Combined with a Chemokine-Modulating Regimen and/or Anti-PD-L1.
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 777, doi. 10.3390/vaccines12070777
- By:
- Publication type:
- Article
Novel Prognosis and Therapeutic Response Model of Immune-Related lncRNA Pairs in Clear Cell Renal Cell Carcinoma.
- Published in:
- Vaccines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/vaccines10071161
- By:
- Publication type:
- Article
Genetic Modification of T Cells for the Immunotherapy of Cancer.
- Published in:
- Vaccines, 2022, v. 10, n. 3, p. 457, doi. 10.3390/vaccines10030457
- By:
- Publication type:
- Article
Neutrophil and Natural Killer Cell Interactions in Cancers: Dangerous Liaisons Instructing Immunosuppression and Angiogenesis.
- Published in:
- Vaccines, 2021, v. 9, n. 12, p. 1488, doi. 10.3390/vaccines9121488
- By:
- Publication type:
- Article
PRC1 plays an important role in lung adenocarcinoma and is potentially targeted by fostamatinib.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2022, v. 26, n. 23, p. 8924
- By:
- Publication type:
- Article
A novel nomogram associated with regulatory T cells infiltration by weighted gene co-expression network analysis for predicting survival in patients with colon cancer.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2022, v. 26, n. 21, p. 8073
- By:
- Publication type:
- Article
The impact of tumor-infiltrating lymphocytes on tumor features and pathological characteristics in breast cancer patients: the role of cytotoxic T lymphocytes and regulatory T cells.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2022, v. 26, n. 12, p. 4207
- By:
- Publication type:
- Article
Nutritional competition within tumor microenvironment dictates anti-tumor immunity.
- Published in:
- National Science Review, 2024, v. 11, n. 2, p. 1, doi. 10.1093/nsr/nwad277
- By:
- Publication type:
- Article
Chemogenetic modulation of sensory neurons reveals their regulating role in melanoma progression.
- Published in:
- Acta Neuropathologica Communications, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40478-021-01273-9
- By:
- Publication type:
- Article
Targeting the Tumor Immune Microenvironment Could Become a Potential Therapeutic Modality for Aggressive Pituitary Adenoma.
- Published in:
- Brain Sciences (2076-3425), 2023, v. 13, n. 2, p. 164, doi. 10.3390/brainsci13020164
- By:
- Publication type:
- Article
Tumor-Infiltrating Immune Cells and HLA Expression as Potential Biomarkers Predicting Response to PD-1 Inhibitor Therapy in Stage IV Melanoma Patients.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 12, p. 1609, doi. 10.3390/biom14121609
- By:
- Publication type:
- Article
Defining Melanoma Immune Biomarkers—Desert, Excluded, and Inflamed Subtypes—Using a Gene Expression Classifier Reflecting Intratumoral Immune Response and Stromal Patterns.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 2, p. 171, doi. 10.3390/biom14020171
- By:
- Publication type:
- Article
High PD-L1 Expression Correlates with an Immunosuppressive Tumour Immune Microenvironment and Worse Prognosis in ALK -Rearranged Non-Small Cell Lung Cancer.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 6, p. 991, doi. 10.3390/biom13060991
- By:
- Publication type:
- Article
Screening and Identification of a Prognostic Model of Ovarian Cancer by Combination of Transcriptomic and Proteomic Data.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 4, p. 685, doi. 10.3390/biom13040685
- By:
- Publication type:
- Article
Reduced Expression of KRT17 Predicts Poor Prognosis in HER2 high Breast Cancer.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 9, p. 1183, doi. 10.3390/biom12091183
- By:
- Publication type:
- Article
Spatial transcriptomics deciphers the immunosuppressive microenvironment in colorectal cancer with tumour thrombus.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 12, p. 1, doi. 10.1002/ctm2.70112
- By:
- Publication type:
- Article
Tumour organoids and assembloids: Patient‐derived cancer avatars for immunotherapy.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 4, p. 1, doi. 10.1002/ctm2.1656
- By:
- Publication type:
- Article
Resolving the heterogeneous tumour microenvironment in cardiac myxoma through single‐cell and spatial transcriptomics.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 2, p. 1, doi. 10.1002/ctm2.1581
- By:
- Publication type:
- Article
Combining TIGIT blockade with IL‐15 stimulation is a promising immunotherapy strategy for lung adenocarcinoma.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 1, p. 1, doi. 10.1002/ctm2.1553
- By:
- Publication type:
- Article
Unravelling the role of immune cells and FN1 in the recurrence and therapeutic process of skull base chordoma.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 10, p. 1, doi. 10.1002/ctm2.1429
- By:
- Publication type:
- Article
Long noncoding RNA Regulating ImMune Escape regulates mixed lineage leukaemia protein‐1‐H3K4me3‐mediated immune escape in oesophageal squamous cell carcinoma.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 9, p. 1, doi. 10.1002/ctm2.1410
- By:
- Publication type:
- Article
Single‐cell transcriptome analysis reveals functional changes in tumour‐infiltrating B lymphocytes after chemotherapy in oesophageal squamous cell carcinoma.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 1, p. 1, doi. 10.1002/ctm2.1181
- By:
- Publication type:
- Article
Prognostic role of inflammatory diets in colorectal cancer overall and in strata of tumor‐infiltrating lymphocyte levels.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 11, p. 1, doi. 10.1002/ctm2.1114
- By:
- Publication type:
- Article
FMO4 shapes immuno‐metabolic reconfiguration in hepatocellular carcinoma.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 2, p. 1, doi. 10.1002/ctm2.740
- By:
- Publication type:
- Article
Neoadjuvant chemotherapy alters peripheral and tumour-infiltrating immune cells in breast cancer revealed by single-cell RNA sequencing.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 12, p. 1, doi. 10.1002/ctm2.621
- By:
- Publication type:
- Article
Immunogenomic alterations of head and neck squamous cell carcinomas stratified by smoking status.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 11, p. 1, doi. 10.1002/ctm2.599
- By:
- Publication type:
- Article
Establishment and validation of a gasdermin signature to evaluate the immune status and direct risk‐group classification in luminal‐B breast cancer.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 11, p. 1, doi. 10.1002/ctm2.614
- By:
- Publication type:
- Article
BTB/POZ domain‐containing protein 7/hypoxia‐inducible factor 1 alpha signalling axis modulates hepatocellular carcinoma metastasis.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 10, p. 1, doi. 10.1002/ctm2.556
- By:
- Publication type:
- Article
Assessment of the immune landscapes of advanced ovarian cancer in an optimized in vivo model.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 10, p. 1, doi. 10.1002/ctm2.551
- By:
- Publication type:
- Article
Tumor‐infiltrating CD8<sup>+</sup> T cell is prognostic and predicts adjuvant chemotherapy benefit in patients with limited‐stage small cell esophageal carcinoma.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 6, p. 1, doi. 10.1002/ctm2.456
- By:
- Publication type:
- Article
Corrigendum: Identification of differentially expressed hub genes associated with immune cell recruitment in claudin-low breast cancer.
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2023.1335637
- By:
- Publication type:
- Article
Identification of Differentially Expressed Hub Genes Associated With Immune Cell Recruitment in Claudin-Low Breast Cancer.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2022.848206
- By:
- Publication type:
- Article
Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1259314
- By:
- Publication type:
- Article
Genomic profiling and immune landscape of olfactory neuroblastoma in China.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1226494
- By:
- Publication type:
- Article
A transcriptional evaluation of the melanoma and squamous cell carcinoma TIL compartment reveals an unexpected spectrum of exhausted and functional T cells.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1200387
- By:
- Publication type:
- Article
β3GNT9 as a prognostic biomarker in glioblastoma and its association with glioblastoma immune infiltration, migration and invasion.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1214413
- By:
- Publication type:
- Article